Jeffrey P. Bruce
University of Toronto(CA)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics, Ovarian cancer diagnosis and treatment, MicroRNA in disease regulation, Cancer-related molecular mechanisms research
Most-Cited Works
- → Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy(2021)476 cited
- → Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial(2021)204 cited
- → The genomic landscape of schwannoma(2016)178 cited
- → Translational genomics of nasopharyngeal cancer(2019)139 cited
- → EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression(2020)128 cited
- → Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity(2021)128 cited
- → Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma(2016)116 cited
- → AACR Project GENIE: 100,000 Cases and Beyond(2022)99 cited
- → Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma(2018)99 cited
- → Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial(2019)66 cited